Baseline Heterogeneity of Myeloid and Stroma Cells to Predict Pcr, Baseline Lymph Node (LN) Metastasis, and 1-Year EFS in Locally Advanced ESCC with Neoadjuvant Immunotherapy: Final Results from a Single-Arm, Phase II Clinical Trial (SEEK-01).
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined